Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients With Advanced Melanoma, Non-Small Cell Lung Cancer, or Bladder CancerCell 2020 Oct 15;183(2)347-362.e24, PA Ott, S Hu-Lieskovan, B Chmielowski, R Govindan, A Naing, N Bhardwaj, K Margolin, MM Awad, MD Hellmann, JJ Lin, T Friedlander, ME Bushway, KN Balogh, TE Sciuto, V Kohler, SJ Turnbull, R Besada, RR Curran, B Trapp, J Scherer, A Poran, D Harjanto, D Barthelme, YS Ting, JZ Dong, Y Ware, Y Huang, Z Huang, A Wanamaker, LD Cleary, MA Moles, K Manson, J Greshock, ZS Khondker, E Fritsch, MS Rooney, M DeMario, RB Gaynor, L Srinivasan
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.